🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7517531

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of den

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517849

Inhibition of ABC transporters by transmembrane domain analogs

The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517527

Immunotoxin with in vivo T cell suppressant activity and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514415

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514529

Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514414

Suppressors of CpG oligonucleotides and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7511015

Modified defensins and their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7511032

Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related th

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507538

Human papilloma virus immunoreactive peptides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7504430

Maleiimide anti-tumor phosphatase inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7504243

Methods for the production of biliverdin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501132

Multiple antigenic peptides immunogenic against Streptococcus pneumonia

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501501

MHC-Class II restricted melanoma antigens and their use in therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498336

Deazaflavin compounds and methods of use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491798

Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, c

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488710

SFRP and peptide motifs that interact with SFRP and methods of their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485440

Production of attenuated respiratory syncytial virus vaccines involving modification of M2

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485415

Sequence analysis of the tetravalent rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479280

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7476535

TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7470506

Fitness assay and associated methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7470775

Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7470430

Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468352

Mutated anthrax toxin protective antigen proteins that specifically target cells containin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted